King names new chief commercial officer

BRISTOL, Tenn. Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing, managed care, sales operations and business analytics for the drug maker.

BRISTOL, Tenn. Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing, managed care, sales operations and business analytics for the drug maker.

Bailey most recently served in a general management capacity for a significant profit center at Novartis and serves on the company's North American Executive Committee. Bailey also has held senior leadership roles for a private equity firm and for Johnson & Johnson, where he was responsible for managing products in the pain therapeutic category and for launching new medicines for pain management.

"We are extremely pleased that Jeff has decided to join our team," stated Brian Markison, King's chairman, president and CEO. "With Remoxy and Acurox resubmissions on track, it is critical that we have an inspirational leader with a broad range of pharmaceutical experience. I am looking forward to Jeff making a significant contribution to the company."